Scienture Holdings, Inc.(SCNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SCNX Scienture Holdings, Inc.

Pre-Mkt 05-27 06:08:42 EDT

0.4000

-0.0020

-0.50%

盘前0.4000

+0.00000.00%

05:39 EDT

High0.4084	Low0.3923	Vol166.62K
Open0.4000	D1 Closing0.4020	Amplitude4.01%
Mkt Cap16.25M	Tradable Cap13.60M	Total Shares40.63M
T/O66.56K	T/O Rate0.49%	Tradable Shares33.99M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SCNX","market":"US","secType":"STK","nameCN":"Scienture Holdings, Inc.","latestPrice":0.4,"timestamp":1779825600000,"preClose":0.402,"halted":0,"volume":166615,"hourTrading":{"tag":"盘前","latestPrice":0.4,"preClose":0.4,"latestTime":"05:39 EDT","volume":861,"amount":344.26308378,"timestamp":1779874796950,"change":0,"changeRate":0,"amplitude":0.0035},"delay":0,"changeRate":-0.004975124378109457,"floatShares":33992500,"shares":40630815,"eps":-1.807909,"marketStatus":"Pre-Mkt","change":-0.002,"latestTime":"05-27 06:08:42 EDT","open":0.4,"high":0.4084,"low":0.3923,"amount":66563.5089135,"amplitude":0.04005,"askPrice":0.453,"askSize":100,"bidPrice":0.3658,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.807909,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779888600000},"marketStatusCode":1,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":0.4,"preHourTrading":{"tag":"盘前","latestPrice":0.4,"preClose":0.4,"latestTime":"05:39 EDT","volume":861,"amount":344.26308378,"timestamp":1779874796950,"change":0,"changeRate":0,"amplitude":0.0035},"postHourTrading":{"tag":"盘后","latestPrice":0.3907,"preClose":0.4,"latestTime":"19:35 EDT","volume":8131,"amount":3195.0301,"timestamp":1779838554639,"change":-0.0093,"changeRate":-0.02325,"amplitude":0.024},"volumeRatio":0.5730971759646749},"requestUrl":"/m/hq/s/SCNX/wiki","defaultTab":"wiki","newsList":[{"id":"2636751920","title":"Scienture Holdings Q1 revenue jumps on Arbli sales, operating expenses steady","url":"https://stock-news.laohu8.com/highlight/detail?id=2636751920","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636751920?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:47","pubTimestamp":1779108439,"startTime":"0","endTime":"0","summary":"Scienture Holdings Q1 revenue jumps on Arbli sales, operating expenses steadyOverviewUS specialty pharma firm's Q1 revenue rose 449% yr/yr on increased Arbli product ordersGross margin expanded to 95.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nL1N41V0HT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636075580","title":"Scienture Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2636075580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636075580?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:38","pubTimestamp":1779107881,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nTUA5TQLJR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636907553","title":"Scienture Holdings, Inc Q1 Gross Profit USD 54 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2636907553","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636907553?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:38","pubTimestamp":1779107880,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nPLX8482DA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636075538","title":"Scienture Holdings, Inc Q1 Operating Expenses USD 3.56 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2636075538","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636075538?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:38","pubTimestamp":1779107880,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nPLX8482DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636407551","title":"SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2636407551","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636407551?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:38","pubTimestamp":1779107880,"startTime":"0","endTime":"0","summary":"COMMACK, NY, May  18, 2026  (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”), a holding company for existing and planned pharmaceutical operating companies focused on providin","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/18/3296641/0/en/SCIENTURE-Reports-First-Quarter-2026-Financial-Results-and-Business-Update-Highlighted-by-Significant-Revenue-Growth-and-Gross-Margin-Expansion.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX","ARB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635053097","title":"Scienture Holdings Q1 EPS $(0.08) Beats $(0.22) Estimate, Sales $56.325K Up From $10.258K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2635053097","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635053097?lang=en_us&edition=fundamental","pubTime":"2026-05-16 06:12","pubTimestamp":1778883129,"startTime":"0","endTime":"0","summary":"Scienture Holdings (NASDAQ:SCNX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.22) by 63.64 percent. This is a 75.76 percent increase over losses of $(0.33) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52620165/scienture-holdings-q1-eps-0-08-beats-0-22-estimate-sales-56-325k-up-from-10-258k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Scienture Holdings Q1 EPS $(0.08) Beats $(0.22) Estimate, Sales $56.325K Up From $10.258K YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635794030","title":"Scienture net loss widens 11% to $3.4 million in Q1 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2635794030","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635794030?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:41","pubTimestamp":1778877663,"startTime":"0","endTime":"0","summary":"Scienture Holdings posted a net loss of $3.4 million for quarter ended March 31, 2026, widening 11% year over year.Revenue climbed to $56,325, up 449% from year earlier, as wholesale distribution sales of SCN-102  continued to ramp following its commercial launch.Research and development expense rose to $793,984, up 38%, driven by higher contract research organization costs tied to advancing pipeline candidates.Cash fell to $3.54 million at March 31, 2026, down 47% from year-end 2025, while net cash used in operating activities was $2.92 million, down 1% year over year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scienture Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Ga","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL3Mm8ZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635030289","title":"Scienture Holdings Inc  expected to post a loss of 22 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2635030289","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635030289?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:38","pubTimestamp":1778877488,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc  expected to post a loss of22cents a share - Earnings Preview Scienture Holdings Inc SCNX.OQ SCNX.O is expected to  report resultson May 18 (estimated) for the period ending Mar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL8N41S23V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634965462","title":"Scienture Holdings Inc  expected to post a loss of 22 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634965462","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634965462?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:36","pubTimestamp":1778272567,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc  expected to post a loss of22cents a share - Earnings Preview Scienture Holdings Inc SCNX.OQ SCNX.O is expected to  report resultson May 11 (estimated) for the period ending Mar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L2LI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144765","title":"BRIEF-Scienture Secures $11.0 Million In Non-Dilutive Debt Financing To Accelerate Growth Of Approved Product Portfolio And Advancement Of Research And Development Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144765","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633144765?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:15","pubTimestamp":1778156137,"startTime":"0","endTime":"0","summary":"BRIEF-Scienture Secures $11.0 Million In Non-Dilutive Debt Financing To Accelerate Growth Of Approved Product Portfolio And Advancement Of Research And Development PipelineMay 7 (Reuters) - Scienture ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA7DRZXY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633514428","title":"Scienture secures $11 million non-dilutive debt financing from institutional investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2633514428","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633514428?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:13","pubTimestamp":1778156021,"startTime":"0","endTime":"0","summary":"Scienture secured $11 million in non-dilutive debt financing via a note purchase agreement with an institutional investor.Financing included two non-convertible promissory notes: $8.42 million promissory note, $3 million secured promissory note.Net proceeds of about $11 million earmarked for commercialization of Arbli and REZENOPY, with additional funding for clinical development of pipeline programs.Transaction disclosed in a Form 8-K filed May 1, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLbtCHGR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4167","SG9999014013.SGD","IE00B64PRP62.GBP","LU2095319765.USD","SCNX","BK4112","LU0314104364.USD","SG9999014005.SGD","NDAQ","IE00BGHQF748.EUR","BK4585","IE00BKPKM429.USD","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","SG9999014021.USD","SG9999014039.USD","LU2210150020.SGD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144476","title":"Scienture Holdings - Enters Definitive Agreement With Summit Biosciences for Exclusive U.S. Rights to Commercialize Rezenopy","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144476","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633144476?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:05","pubTimestamp":1778155500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA7DRZXY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633092144","title":"Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2633092144","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633092144?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:05","pubTimestamp":1778155500,"startTime":"0","endTime":"0","summary":"Proceeds support commercialization of Arbli, the first FDA-approved ready-to-use oral suspension for hypertension; and REZENOPY, life-saving opioid overdose emergency treatment Financing also drives e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3289973/0/en/Scienture-Secures-11-0-Million-in-Non-Dilutive-Debt-Financing-to-Accelerate-Growth-of-Approved-Product-Portfolio-and-Advancement-of-R-D-Pipeline.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SCNX","BK4585","LABU","BK4167","AAQC","ARB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633193086","title":"Scienture announces third patent granted for Arbli","url":"https://stock-news.laohu8.com/highlight/detail?id=2633193086","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633193086?lang=en_us&edition=fundamental","pubTime":"2026-05-07 11:50","pubTimestamp":1778125806,"startTime":"0","endTime":"0","summary":"Scienture (SCNX) announced that the United States Patent and Trademark Office has granted its third patent covering Arbli oral suspension, the firs...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-announces-third-patent-granted-for-arbli-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-announces-third-patent-granted-for-arbli-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633387911","title":"Scienture wins third US patent for ARBLI oral suspension, protection through 2041","url":"https://stock-news.laohu8.com/highlight/detail?id=2633387911","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633387911?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:10","pubTimestamp":1778069433,"startTime":"0","endTime":"0","summary":"Scienture won a third US patent covering ARBLI, a ready-to-use oral suspension of losartan potassium.USPTO issued US Patent No. 12,605,365 on April 21, 2026; protection expected to run through Oct. 7, 2041.ARBLI is positioned for US losartan market estimated at $241 million in annual sales with about 72 million prescriptions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL7gN3KW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BN0W2T93.GBP","BK4588","SG9999014039.USD","SCNX","BK4112","IE00BN0W2V16.EUR","NDAQ","BK4585","BK4167","LU2210150020.SGD","IE00BGHQF748.EUR","LU2095319765.USD","IE00B64PRP62.GBP","SG9999014021.USD","SG9999014013.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633389901","title":"Scienture Announces Third Patent Grant for Arbli™ (Losartan Potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041","url":"https://stock-news.laohu8.com/highlight/detail?id=2633389901","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633389901?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:05","pubTimestamp":1778069100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nTUA7SMFDR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632918628","title":"Scienture Holdings closes USD 11.42 million secured note financing with Streeterville Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2632918628","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632918628?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:26","pubTimestamp":1777670781,"startTime":"0","endTime":"0","summary":"Scienture Holdings closed note purchase agreement with Streeterville Capital on April 27, 2026 for two secured promissory notes totaling USD 11.42 million.Streeterville funded USD 8 million at closing; additional USD 3 million was deposited into controlled account held by wholly owned subsidiary SCNX Holdings under deposit account control agreement with Lakeside Bank.Secured Promissory Note A-1 has USD 8.42 million principal, USD 400,000 original issue discount, 9% interest; principal due 18 months from issuance.Secured Promissory Note B has USD 3 million principal, 5% interest; principal due 18 months from issuance.Terms allow monthly lender redemptions starting eight months post-close; both notes permit prepayment, including 115% premium tied to third-party refinancing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational pu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL7RnyyB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627628096","title":"Scienture granted 180-day extension to meet Nasdaq minimum bid price","url":"https://stock-news.laohu8.com/highlight/detail?id=2627628096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627628096?lang=en_us&edition=fundamental","pubTime":"2026-04-15 21:37","pubTimestamp":1776260273,"startTime":"0","endTime":"0","summary":"Scienture (SCNX) Holdings announced it received notification from Nasdaq approving the company’s request for an additional 180-calendar day extensi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-granted-180-day-extension-to-meet-nasdaq-minimum-bid-price-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-granted-180-day-extension-to-meet-nasdaq-minimum-bid-price-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","SCNX","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627849792","title":"Scienture Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2627849792","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627849792?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:05","pubTimestamp":1776254700,"startTime":"0","endTime":"0","summary":"COMMACK, NY, April  15, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”) a holding company for existing and planned pharmaceutical operating companies focused on providin","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/15/3274413/0/en/Scienture-Granted-180-Day-Extension-by-Nasdaq-to-Regain-Compliance-with-Minimum-Bid-Price-Requirement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1165135440.EUR","LU2229751404.USD","BK4167","LU2413666426.HKD","IE00BN0W2V16.EUR","LU1721428933.USD","SCNX","LU0347712357.USD","BK4585","IE00BN0W2W23.USD","LU2092937221.SGD","LU2041044095.USD","LU2413666699.HKD","ARB","LU2089279066.USD","IE00BN0W2T93.GBP","A","BK4588","LU1543694498.USD","BK4121","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625797216","title":"Scienture Provides Annual Shareholder Update, Outlining Significant Progress and Strategic Priorities for the Year Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2625797216","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625797216?lang=en_us&edition=fundamental","pubTime":"2026-04-06 20:05","pubTimestamp":1775477100,"startTime":"0","endTime":"0","summary":"COMMACK, NY, April  06, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”) a holding company for existing and planned pharmaceutical operating companies focused on providin","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/06/3268403/0/en/Scienture-Provides-Annual-Shareholder-Update-Outlining-Significant-Progress-and-Strategic-Priorities-for-the-Year-Ahead.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","LU2065732104.USD","BK4097","PRGS","ARB","BK4167"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scientureholdings.com","stockEarnings":[{"period":"1week","weight":0.0256},{"period":"1month","weight":-0.0249},{"period":"3month","weight":-0.0588},{"period":"6month","weight":-0.3242},{"period":"1year","weight":-0.5436},{"period":"ytd","weight":-0.2157}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.0513},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.1043},{"period":"1year","weight":0.2961},{"period":"ytd","weight":0.1007}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.119636},{"month":2,"riseRate":0.333333,"avgChangeRate":0.150517},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.073293},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.066727},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.0952},{"month":6,"riseRate":1,"avgChangeRate":0.56391},{"month":7,"riseRate":0.666667,"avgChangeRate":0.096061},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.16799},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.047954},{"month":10,"riseRate":0,"avgChangeRate":-0.160548},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.067192},{"month":12,"riseRate":0,"avgChangeRate":-0.185859}],"exchange":"NASDAQ","name":"Scienture Holdings, Inc.","nameEN":"Scienture Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Scienture Holdings, Inc.(SCNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Scienture Holdings, Inc.(SCNX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Scienture Holdings, Inc.,SCNX,Scienture Holdings, Inc.股票,Scienture Holdings, Inc.股票老虎,Scienture Holdings, Inc.股票老虎国际,Scienture Holdings, Inc.行情,Scienture Holdings, Inc.股票行情,Scienture Holdings, Inc.股价,Scienture Holdings, Inc.股市,Scienture Holdings, Inc.股票价格,Scienture Holdings, Inc.股票交易,Scienture Holdings, Inc.股票购买,Scienture Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Scienture Holdings, Inc.(SCNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Scienture Holdings, Inc.(SCNX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction